Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Hepatology Hepatology for November/December 2020 Endoscopic intragastric balloon improved NASH parameters, HCC rates slow in cities, continue to climb in rural areas, Liver-related deaths decline after Medicaid expansion under ACA, Liquid biopsy captures key NASH pathology hallmarks, Semaglutide shows promise in NASH phase 2 study, More must reads Hepatology for July/August 2020 Women suffer less NAFLD but more advanced fibrosis, More must readsHepatology for May/June 2020 Medicare claims review builds case for NAFLD/NASH screening, More must readsHepatology for March/April 2020 Noninvasive fibrosis scores not sensitive in people with fatty liver disease and T2D, HCV screening risk factors in pregnant women need updating, More must readsHepatology for November/December 2019 TARGET-NASH: One-third of NAFLD, NASH patients lost weight, but not all kept it off, ED-based HCV screening found feasible, linkage low, Kratom: Botanical with opiate-like effects increasingly blamed for liver injury, More must readsPages1 2 3 last »
